Stock Events

Stock Events

Meadow Bay Gold 

0
14
+C$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-4,300%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
65,000Revenue
-2.8MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics is involved in gene editing, a cutting-edge area of medicine that could overlap with Mountain Valley MD's work in advanced health technologies.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals engages in creating new therapies for treating cystic fibrosis and other diseases, competing in the biotech space where innovative treatments are key.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that develops medicines in areas of unmet medical needs, similar to Mountain Valley MD's mission to improve global health outcomes.
Moderna
MRNA
Mkt Cap88.52B
Moderna is known for its mRNA technology used in vaccines, which competes with Mountain Valley MD's focus on drug delivery technologies and health solutions.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a large pharmaceutical company with a broad range of products that could compete across several of Mountain Valley MD's target areas, including vaccine technologies.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a diversified healthcare giant that competes with Mountain Valley MD in multiple areas, including pharmaceuticals and wellness products.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in the pharmaceutical industry, focusing on innovative therapies, which puts it in competition with Mountain Valley MD's health technology advancements.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a biotech firm that develops novel therapeutics, potentially competing with Mountain Valley MD's proprietary technology and health solutions.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a global biopharmaceutical company that develops drugs in several therapeutic areas, competing with Mountain Valley MD's approach to health and wellness.

About

The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.
Show More
CEO
Dennis Hancock
Employees
1
Country
Canada
ISIN
CA5830812031
WKN
000A42J37

Listings

CN
CA
MLCO.CN
F
DE
20M.F
OTC Link
US
TMLCF
MU
DE
20MP.MU

0 Comments

Share your thoughts

FAQs

What is Meadow Bay Gold stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Meadow Bay Gold stocks are traded under the ticker MAY.CN.
What is Meadow Bay Gold revenue for the last year?▼
Meadow Bay Gold revenue for the last year amounts to 65,000 CAD.
What is Meadow Bay Gold net income for the last year?▼
MAY.CN net income for the last year is -2.8M CAD.
How many employees does Meadow Bay Gold have?▼
As of November 3, 2026, the company has 1 employees.
In which sector is Meadow Bay Gold located?▼
Meadow Bay Gold operates in the Health & Wellness sector.
When did Meadow Bay Gold complete a stock split?▼
The last stock split for Meadow Bay Gold was on March 2, 2020 with a ratio of 1:8.
Where is Meadow Bay Gold headquartered?▼
Meadow Bay Gold is headquartered in Concord, Canada.